Reuters logo
Hospira swings to profit in fourth quarter as sales rise
February 13, 2013 / 1:06 PM / 5 years ago

Hospira swings to profit in fourth quarter as sales rise

Feb 13 (Reuters) - Injectable drug provider Hospira Inc on Wednesday reported a profit for the fourth quarter versus a year-earlier loss as its sales increased more than 8 percent.

Net income was $5.3 million, or 3 cents per share, in the latest quarter, compared with a net loss of $214.0 million, or $1.30 per share, in the year-earlier period.

Adjusted earnings were 55 cents per share. On that basis, analysts on average were expecting earnings per share of 54 cents.

Net sales jumped to $1.1 billion in the quarter from $1.0 billion a year before.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below